Ceesay Abraham sold PCRX
September 4, 2025 · Form 4 insider transaction
Ceesay Abraham sold 2,354 shares of Pacira BioSciences, Inc. at $27.19 per share, a transaction worth $64.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,354
Price
$27.19
Total value
$64.0K
InsiderCeesay Abraham
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 4, 2025
Filing dateSeptember 8, 2025
Shares owned after9,039
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.